DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
19 hedge funds and large institutions have $89.1M invested in DermTech, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 2
58% more funds holding
Funds holding: 12 → 19 (+7)
43% more capital invested
Capital invested by funds: $62.1M → $89.1M (+$27M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
+$11.2M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$8.59M |
| 3 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
+$3.84M |
| 4 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$1.46M |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$1.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Cowen Inc
New York
|
-$2.44M |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$492K |
DMTK Hedge Fund Activity: Q4 2017 in Review
19 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q4 2017, worth a combined $89.1M — up 43% from $62.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new DMTK positions and 0 closed out — a net gain of 7 holders — while 6 added to existing stakes and 2 trimmed.
The largest buyer was Boothbay Fund Management, opening a new position worth an estimated $11.2M. The largest seller was Cowen Inc, cutting an estimated $2.44M.
- 19 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q4 2017, up from 12 in Q3 2017.
- Funds reported $89.1M of DermTech, Inc. Common Stock stock for Q4 2017, up 43% quarter-over-quarter.
- 7 funds opened new DermTech, Inc. Common Stock positions in Q4 2017 and 0 closed out, a net change of +7 holders.
- The largest DermTech, Inc. Common Stock buyer in Q4 2017 was Boothbay Fund Management, an estimated $11.2M added.
- The largest DermTech, Inc. Common Stock seller in Q4 2017 was Cowen Inc, an estimated $2.44M sold.
Based on aggregated 13F filings for Q4 2017.